Advertisement
Screener

LIQUIDIA CORPORATION (LQDA) Material Contracts

LIQUIDIA CORPORATION Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2026-03-05: Form 10-K; Exhibit 10.55; Description License Agreement, dated as of October 27, 2025, by and between Liquidia Technologies, Inc. and Vectura Limited..
  • 2026-03-05: Form 10-K; Exhibit 10.14; Description Amendment to Restricted Stock Units Agreement under the Liquidia Corporation 2020 Long-Term Incentive Plan..
  • 2026-03-05: Form 10-K; Exhibit 10.13; Description Amendment to Restricted Stock Units Notice (Performance Based) under the Liquidia Corporation 2020 Long-Term Incentive Plan..
  • 2026-03-05: Form 10-K; Exhibit 10.12; Description Amendment to Stock Option Agreement under the Liquidia Corporation 2020 Long-Term Incentive Plan..
FiledFormExhibitDescription
2026-03-0510-K10.55License Agreement, dated as of October 27, 2025, by and between Liquidia Technologies, Inc. and Vectura Limited.
2026-03-0510-K10.14Amendment to Restricted Stock Units Agreement under the Liquidia Corporation 2020 Long-Term Incentive Plan.
2026-03-0510-K10.13Amendment to Restricted Stock Units Notice (Performance Based) under the Liquidia Corporation 2020 Long-Term Incentive Plan.
2026-03-0510-K10.12Amendment to Stock Option Agreement under the Liquidia Corporation 2020 Long-Term Incentive Plan.
2026-03-0510-K10.11Amendment to Stock Option Grant Notice under the Liquidia Technologies, Inc. 2016 Equity Incentive Plan, the Liquidia Technologies, Inc. 2018 Long-Term Incentive Plan, and the Liquidia Corporation 2022 Inducement Plan.
2025-08-1210-Q10.1Indenture of Lease, dated as of June 16, 2025, by and between Liquidia Technologies, Inc. and King Combs LLC.
2025-03-1910-K10.53First Amendment to Amended and Restated Commercial Manufacturing Services and Supply Agreement, dated January 7, 2025, by and between Liquidia Technologies, Inc. and Lonza Tampa LLC.
2025-03-1910-K10.25Sixth Amendment to Revenue Interest Financing Agreement, dated as of March 17, 2025, by and between Liquidia Technologies, Inc. and Healthcare Royalty Partners IV, L.P.
2024-11-1310-Q10.5First Amendment to the License Agreement, dated as of October 2, 2024, by and between Liquidia Technologies, Inc. and Pharmosa Biopharm Inc.
2024-11-1310-Q10.4Device License Agreement, dated as of October 2, 2024, by and between Liquidia Technologies, Inc. and Pharmosa Biopharm Inc.
2024-09-128-K10.3Fifth Amendment to Revenue Interest Financing Agreement, dated as of September 11, 2024, by and between Liquidia Technologies, Inc. and Healthcare Royalty Partners IV, L.P.
2024-09-128-K10.2Registration Rights Agreement by and among Liquidia Corporation and the Purchasers, dated September 10, 2024.
2024-09-128-K10.1Common Stock Purchase Agreement by and among Liquidia Corporation and the Purchasers, dated September 10, 2024.
2024-05-148-K10.1Liquidia Corporation Amended and Restated Executive Severance and Change in Control Plan
2024-03-1310-K10.51Supply Agreement, dated May 22, 2023, by and between Liquidia Technologies, Inc. and Plastiape SpA.
2024-03-1310-K10.50Asset Transfer Agreement, dated as of June 28, 2023, by and between Liquidia Technologies, Inc. and Pharmosa Biopharm Inc.
2024-03-1310-K10.49License Agreement, dated as of June 28, 2023, by and between Liquidia Technologies, Inc. and Pharmosa Biopharm Inc.
2024-03-1310-K10.47Amended and Restated Commercial Manufacturing Services and Supply Agreement, dated July 13, 2023, by and between Liquidia Technologies, Inc. and Lonza Tampa LLC.
2024-03-1310-K10.20Third Amendment to Revenue Interest Financing Agreement, dated as of July 27, 2023, by and between Liquidia Technologies, Inc. and Healthcare Royalty Partners IV, L.P.
2024-03-1310-K10.19Second Amendment to Revenue Interest Financing Agreement, dated as of June 28, 2023, by and between Liquidia Technologies, Inc. and Healthcare Royalty Partners IV, L.P.
2024-03-1310-K10.9Form of Non-Qualified Stock Option Agreement under the Liquidia Corporation 2020 Long-Term Incentive Plan.
2024-03-1310-K10.8Form of Incentive Stock Option Agreement under the Liquidia Corporation 2020 Long-Term Incentive Plan.
2024-03-1310-K10.7Form of Restricted Stock Units Agreement (Performance-Based) under the Liquidia Corporation 2020 Long-Term Incentive Plan.
2024-03-1310-K10.6Form of Restricted Stock Units Agreement under the Liquidia Corporation 2020 Long-Term Incentive Plan.
2024-03-1310-K10.4Liquidia Corporation 2020 Long-Term Incentive Plan.
2024-01-088-K10.3Registration Rights Agreement, dated as of January 4, 2024, by and between Liquidia Corporation and the Purchaser.
2024-01-088-K10.2Common Stock Purchase Agreement, dated as of January 4, 2024, by and between Liquidia Corporation and the Purchaser.
2024-01-088-K10.1Fourth Amendment to Revenue Interest Financing Agreement, dated as of January 3, 2024, by and between Liquidia Technologies, Inc. and Healthcare Royalty Partners IV, L.P.
2023-12-148-K10.1Purchase Agreement by and between Liquidia Corporation and Roger Jeffs, dated December 12, 2023.
2023-11-0710-Q10.1Liquidia Corporation Policy for Recovery of Erroneously Awarded Incentive Compensation
2023-08-1010-Q10.6Amended and Restated Commercial Manufacturing Services and Supply Agreement, dated July 13, 2023, by and between Liquidia Technologies, Inc. and Lonza Tampa LLC.
2023-08-1010-Q10.5Supply Agreement, dated May 22, 2023, by and between Liquidia Technologies, Inc. and Plastiape SpA.
2023-08-1010-Q10.4Asset Transfer Agreement, dated as of June 28, 2023, by and between Liquidia Technologies, Inc. and Pharmosa Biopharm Inc.
2023-08-1010-Q10.3License Agreement, dated as of June 28, 2023, by and between Liquidia Technologies, Inc. and Pharmosa Biopharm Inc.
2023-08-1010-Q10.2Third Amendment to Revenue Interest Financing Agreement, dated as of July 27, 2023, by and between Liquidia Technologies, Inc. and Healthcare Royalty Partners IV, L.P.
2023-08-1010-Q10.1Second Amendment to Revenue Interest Financing Agreement, dated as of June 28, 2023, by and between Liquidia Technologies, Inc. and Healthcare Royalty Partners IV, L.P.
2023-05-0810-Q10.3First Amendment to Revenue Interest Financing Agreement, dated as of April 17, 2023, by and among Liquidia Technologies, Inc., Healthcare Royalty Partners IV, L.P., and HCR Collateral Management, LLC.
2023-05-0810-Q10.2Research License Agreement, dated as of March 31, 2023, by and between Liquidia Technologies, Inc. and Glaxo Group Limited.
2023-05-0810-Q10.1Fourth Amendment to Promotion Agreement, dated as of March 10, 2023, by and between Liquidia PAH, LLC and Sandoz Inc.
2023-03-2010-K10.43Device Development and Supply Agreement, dated as of December 1, 2022, by and among Mainbridge Health Partners, LLC, Sandoz Inc. and Liquidia PAH, LLC.
2023-03-2010-K10.39Third Amendment to Promotion Agreement, dated as of November 18, 2022 by and between Liquidia PAH, LLC and Sandoz Inc.
2023-03-2010-K10.11Revenue Interest Financing Agreement, dated as of January 9, 2023, by and among Liquidia Technologies, Inc., Healthcare Royalty Partners IV, L.P., and HCR Collateral Management, LLC.
2022-07-018-K10.1Severance Agreement and General Release, dated as of June 28, 2022, by and between Liquidia Technologies, Inc. and Tushar Shah, M.D.
2022-06-228-K10.1Executive Employment Agreement, dated as of June 13, 2022, by and between Liquidia Technologies, Inc. and Rajeev Saggar.
2022-06-178-K10.1Amendment to 2020 Long-Term Incentive Plan.
2022-03-1710-K10.45Commercial Manufacturing Services and Supply Agreement, dated November 12, 2020, by and between Liquidia Technologies, Inc. and Xcelience, LLC.
2022-03-1710-K10.44LIQ861 API Supply Agreement, dated as of January 10, 2020, by and among LGM Pharma LLC, Yonsung Fine Chemicals Co. Ltd. and Liquidia Technologies, Inc.
2022-03-1710-K10.36Amendment No. 1 to the Liquidia Corporation 2020 Employee Stock Purchase Plan.
2022-02-048-K10.1Separation Agreement and General Release, dated as of January 31, 2022, by and between Liquidia Technologies, Inc. and Damian deGoa.
2022-01-318-K10.2Form of Stock Option Grant Notice and Stock Option Agreement under the 2022 Inducement Plan.
2022-01-318-K10.1Liquidia Corporation 2022 Inducement Plan.
2022-01-118-K10.1Amended and Restated Loan and Security Agreement, dated as of January 7, 2022, by and among the Company, Silicon Valley Bank and SVB Innovation Credit Fund VIII, L.P.
2022-01-048-K10.1Executive Employment Agreement, dated as of January 3, 2022, by and between Liquidia Corporation and Roger A. Jeffs, Ph.D.
2021-08-308-K10.1First Loan Modification Agreement, dated as of August 26, 2021, by and among Silicon Valley Bank, Liquidia Corporation, Liquidia Technologies, Inc. and Liquidia PAH, LLC.
2021-04-138-K10.3Standstill Agreement, dated as of April 13, 2021, by and among Liquidia Corporation and Caligan Partners LP.
2021-04-138-K10.2Registration Rights Agreement, dated as of April 12, 2021, by and among Liquidia Corporation and the Purchasers.
2021-04-138-K10.1Common Stock Purchase Agreement, dated as of April 12, 2021, by and among Liquidia Corporation and the Purchasers.
2021-03-2510-K10.28Liquidia Corporation Executive Severance and Change in Control Plan.
2021-03-2510-K10.23Executive Employment Agreement, dated as of May 18, 2020, by and between Liquidia Technologies, Inc. and Tushar Shah.
2021-03-2510-K10.4Liquidia Corporation 2020 Long-Term Incentive Plan, and forms of award agreements thereunder.
2021-03-038-K10.1Loan and Security Agreement, dated as of February 26, 2021, by and among Silicon Valley Bank, Liquidia Corporation, Liquidia Technologies, Inc. and Liquidia PAH, LLC.
2021-01-148-K10.1Severance Agreement and General Release, dated as of January 13, 2021, by and between Liquidia Technologies, Inc. and Neal F. Fowler.
2020-12-168-K10.2Nonstatutory Stock Option Agreement, dated as of December 15, 2020, by and between Liquidia Corporation and Damian deGoa.
2020-12-168-K10.1Executive Employment Agreement, dated as of December 14, 2020, by and between Liquidia Technologies, Inc. and Damian deGoa.
2020-12-018-K10.1Executive Employment Agreement, dated as of November 30, 2020, by and between Liquidia Technologies, Inc. and Michael Kaseta.

Similar stocks

Stock NameCountryMarket CapPE Ratio
Amneal Pharmaceuticals, Inc. (AMRX)$6.326B25.62
RHYTHM PHARMACEUTICALS, INC. (RYTM)United States$6.771B-37.20
Alkermes plc. (ALKS)$6.844B132.74
Mirum Pharmaceuticals, Inc. (MIRM)United States$5.798B-8.81
Travere Therapeutics, Inc. (TVTX)United States$5.712B-123.10
Oruka Therapeutics, Inc. (ORKA)United States$5.663B-43.76
Cogent Biosciences, Inc. (COGT)United States$5.450B-17.61
IONIS PHARMACEUTICALS INC (IONS)United States$7.277B-23.25
Gossamer Bio, Inc. (GOSS)United States$5.355B-0.65
PTC THERAPEUTICS, INC. (PTCT)United States$5.199B-177.07